noom for glp 1 Med Noom Eyes GLP-1s for Longevity,
Description
liraglutide (Victoza, Saxenda), approved in 2010 and 2014 for treating T2DM and obesity, respectively
Monitoring is essential, especially in the first three months of combination therapy
The GI consequences are severe
The other senior author is Markus Stoffel, MD, PhD, professor of metabolic diseases at the Institute of Molecular Health Sciences, ETH Zurich in Switzerland
